Physician profile
Ajay Soodan
NPI 1336175884
$11,876.82
in general payments reported to CMS, 2019-2025
27 companies · $1,131 in 2025
The $1,131 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,629 · 2020: $60.94 · 2021: $2,193 · 2022: $2,733 · 2023: $599 · 2024: $531 · 2025: $1,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,262.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,261.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,759.90 | 2021-2025 | Azure Xt Dr Mri Surescan, Affera Mapping System, Micra |
| Medtronic Vascular, INC. | $3,899.35 | 2019 | |
| Abbott Laboratories | $532.72 | 2019-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Ensite Precision, Assurity |
| Boston Scientific Corporation | $386.82 | 2019-2025 | Farapulse, Rhythmia Mapping System, Watchman Access System |
| Biosense Webster, INC. | $352.02 | 2019-2025 | Carto 3 |
| Kestra Medical Technology Services, INC. | $327.59 | 2023-2025 | Assure Wcd |
| Edwards Lifesciences Corporation | $192.90 | 2024 | Edwards Sapien 3 Transcatheter Heart Valve (Thv) |
| Atricure, INC. | $188.73 | 2023-2024 | |
| Janssen Pharmaceuticals, INC | $168.82 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $165.47 | 2019-2025 | Eliquis, Camzyos |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $145.27 | 2019-2025 | Lifevest |
| Inari Medical, INC. | $124.97 | 2023 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Amarin Pharma, INC. | $115.87 | 2019 | |
| Sanofi-Aventis U.S. LLC | $100.02 | 2019-2021 | |
| Preventice Services, LLC | $75.53 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $71.42 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $71.39 | 2021-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $28.25 | 2023 | Jardiance |
| Daiichi Sankyo INC. | $27.00 | 2024 | Injectafer |
| Philips North America LLC | $22.15 | 2024 | (5091) Amb Mon & Diag Und |
| Akcea Therapeutics, INC. | $19.99 | 2020 | |
| Amryt Pharma Holdings LTD | $19.40 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $18.44 | 2025 | Tagrisso |
| Biotronik INC. | $17.93 | 2020 | |
| Ge Healthcare | $16.49 | 2019 | |
| Amgen INC. | $15.15 | 2022 | |
| Novo Nordisk INC | $13.23 | 2023 | Rybelsus, Ozempic |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ajay Soodan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.